112 related articles for article (PubMed ID: 14697287)
21. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine phosphorylation in DNA damage and cell death in hypoxic injury to LLC-PK1 cells.
Hagar H; Ueda N; Shah SV
Kidney Int; 1997 Jun; 51(6):1747-53. PubMed ID: 9186862
[TBL] [Abstract][Full Text] [Related]
23. Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phosphorylation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors.
Ralph SJ; Wines BD; Payne MJ; Grubb D; Hatzinisiriou I; Linnane AW; Devenish RJ
J Immunol; 1995 Mar; 154(5):2248-56. PubMed ID: 7532663
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase inhibitors, herbimycin A and lavendustin A, block formation of long-term potentiation in the dentate gyrus in vivo.
Abe K; Saito H
Brain Res; 1993 Sep; 621(1):167-70. PubMed ID: 8221070
[TBL] [Abstract][Full Text] [Related]
25. Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced Her-2/neu activation, receptor expression and proliferation of Her-2-positive malignant cell lines.
Hartmann F; Horak EM; Cho C; Lupu R; Bolen JB; Stetler-Stevenson MA; Pfreundschuh M; Waldmann TA; Horak ID
Int J Cancer; 1997 Jan; 70(2):221-9. PubMed ID: 9009164
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of tyrosine kinase inhibitors on antigen-induced tracheal contraction and histamine release in guinea pigs.
Iwagoe H; Kohrogi H; Fujii K; Hamamoto J; Hirata N; Ando M
Int Arch Allergy Immunol; 1996 Nov; 111(3):291-8. PubMed ID: 8917125
[TBL] [Abstract][Full Text] [Related]
27. Involvement of a herbimycin A-sensitive protein tyrosine kinase in extracellular action of HIV-1 Nef.
Haraguchi S; Brigino-Buenaventura EN; Hitchcock R; James-Yarish M; Good RA; Day NK
Immunol Lett; 2001 Jan; 75(2):97-101. PubMed ID: 11137132
[TBL] [Abstract][Full Text] [Related]
28. Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein.
Zhang ZH; Wang Q
Pflugers Arch; 2000 Sep; 440(5):784-92. PubMed ID: 11007322
[TBL] [Abstract][Full Text] [Related]
29. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.
Faris M; Gaskin F; Parsons JT; Fu SM
J Exp Med; 1994 Jun; 179(6):1923-31. PubMed ID: 7515102
[TBL] [Abstract][Full Text] [Related]
30. Specific induction of the 70-kD heat stress proteins by the tyrosine kinase inhibitor herbimycin-A protects rat neonatal cardiomyocytes. A new pharmacological route to stress protein expression?
Morris SD; Cumming DV; Latchman DS; Yellon DM
J Clin Invest; 1996 Feb; 97(3):706-12. PubMed ID: 8609226
[TBL] [Abstract][Full Text] [Related]
31. Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion.
Sorenson RL; Brelje TC; Roth C
Endocrinology; 1994 Apr; 134(4):1975-8. PubMed ID: 8137766
[TBL] [Abstract][Full Text] [Related]
32. Cell proliferation status, cytokine action and protein tyrosine phosphorylation modulate leukotriene biosynthesis in a basophil leukaemia and a mastocytoma cell line.
Hagmann W
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):467-72. PubMed ID: 7513514
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the tyrosine phosphorylation pathway in induction of human heme oxygenase-1 by hemin, sodium arsenite, and cadmium chloride.
Masuya Y; Hioki K; Tokunaga R; Taketani S
J Biochem; 1998 Sep; 124(3):628-33. PubMed ID: 9722676
[TBL] [Abstract][Full Text] [Related]
34. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Avramis IA; Laug WE; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine kinase inhibitors and Ca2+ signaling: direct interactions with fura-2.
Berts A; Minneman KP
Eur J Pharmacol; 2000 Feb; 389(1):35-40. PubMed ID: 10686293
[TBL] [Abstract][Full Text] [Related]
36. Altered regulation of L-type channels by protein kinase C and protein tyrosine kinases as a pathophysiologic effect in retinal degeneration.
Mergler S; Steinhausen K; Wiederholt M; Strauss O
FASEB J; 1998 Sep; 12(12):1125-34. PubMed ID: 9737715
[TBL] [Abstract][Full Text] [Related]
37. Signal transduction-mediated CYP1A1 induction by omeprazole in human HepG2 cells.
Kikuchi H; Hossain A
Exp Toxicol Pathol; 1999 Jul; 51(4-5):342-6. PubMed ID: 10445394
[TBL] [Abstract][Full Text] [Related]
38. Are tyrosine kinases involved in mediating contraction-stimulated muscle glucose transport?
Wright DC; Geiger PC; Han DH; Holloszy JO
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E123-E128. PubMed ID: 16159907
[TBL] [Abstract][Full Text] [Related]
39. Influence of phosphotyrosine kinase inhibitors on adhesive properties of highly and poorly metastatic HT-29 colon carcinoma cells to collagen.
Haier J; Nasralla M; Nicolson GL
Int J Colorectal Dis; 1999 Apr; 14(2):119-27. PubMed ID: 10367258
[TBL] [Abstract][Full Text] [Related]
40. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
Merchant MS; Woo CW; Mackall CL; Thiele CJ
J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
